Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial
Stephen J. Nicholls, Marc Ditmarsch, John J.P. Kastelein, Scott P. Rigby, Douglas Kling, Danielle Curcio, Nicholas John, Michael H. Davidson
Topics & Concepts
Cholesterylester transfer proteinPlaceboMedicineInternal medicineApolipoprotein BStatinCholesterolLipoproteinRandomized controlled trialEndocrinologyPharmacologyGastroenterologyPathologyAlternative medicineLipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyDiabetes, Cardiovascular Risks, and Lipoproteins